lenalidomide has been researched along with Angiohemophilia in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Agis, H; Eichinger-Hasenauer, S; Jeryczynski, G; Krauth, MT | 1 |
| Afraz, S; Cao, J; Green, A; Ibrahim, IF; Nelson, AT; Sarode, R; Shen, YP; Yates, SG | 1 |
| Bull-Henry, K; Kessler, CM; Khatri, NV; Kohli, DR; Patel, B; Solomon, SS | 1 |
| Cameron, E; Symington, E; Thomas, W; Warner, E | 1 |
| Brophy, TM; Browne, PV; Hayden, PJ; Lavin, M; O'Connell, N; O'Donnell, JS; O'Sullivan, JM; Rawley, O; Ryan, K | 1 |
| Brouwer, RE; Heidt, J; Langers, AM; van der Meer, FJ | 1 |
6 other study(ies) available for lenalidomide and Angiohemophilia
| Article | Year |
|---|---|
Successful treatment of acquired von Willebrand syndrome associated with monoclonal gammopathy : Breaking a dangerous bond.
Topics: Cyclophosphamide; Dexamethasone; Hematopoietic Stem Cell Transplantation; Humans; Lenalidomide; Monoclonal Gammopathy of Undetermined Significance; Paraproteinemias; Transplantation, Autologous; von Willebrand Diseases | 2022 |
Successful use of lenalidomide to treat refractory acquired von Willebrand disease associated with monoclonal gammopathy.
Topics: Adult; Humans; Lenalidomide; Male; Monoclonal Gammopathy of Undetermined Significance; Paraproteinemias; von Willebrand Diseases; von Willebrand Factor | 2022 |
Lenalidomide as a novel therapy for gastrointestinal angiodysplasia in von Willebrand disease.
Topics: Aged; Angiodysplasia; Angiogenesis Inhibitors; Female; Humans; Lenalidomide; Male; Retrospective Studies; Thalidomide; von Willebrand Diseases | 2018 |
Successful treatment of acquired von Willebrand disease with lenalidomide leading to dramatic resolution of intractable gastrointestinal bleeding: A case report.
Topics: Aged; Factor VIII; Gastrointestinal Hemorrhage; Humans; Immunoglobulin M; Lenalidomide; Male; Monoclonal Gammopathy of Undetermined Significance; von Willebrand Diseases; von Willebrand Factor | 2018 |
Lenalidomide as a novel treatment for refractory acquired von Willebrand syndrome associated with monoclonal gammopathy.
Topics: Aged; Anticoagulants; Drug Administration Schedule; Hemorrhage; Humans; Lenalidomide; Male; Middle Aged; Multiple Myeloma; Paraproteinemias; Remission Induction; Thalidomide; Treatment Outcome; von Willebrand Diseases; von Willebrand Factor | 2016 |
Thalidomide as treatment for digestive tract angiodysplasias.
Topics: Aged, 80 and over; Angiodysplasia; Gastrointestinal Diseases; Gastrointestinal Hemorrhage; Humans; Lenalidomide; Male; Melena; Recurrence; Thalidomide; Treatment Outcome; von Willebrand Diseases | 2006 |